Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.07.2023 | Case report

Camrelizumab

Reactive cutaneous capillary endothelial proliferation: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Wu R, et al. Anlotinib improved the reactive cutaneous capillary endothelial proliferation induced by camrelizumab: a case report. Translational Cancer Research 11 : 2940-2945, No. 8, Aug 2022. Available from: URL: http://doi.org/10.21037/tcr-22-426 Wu R, et al. Anlotinib improved the reactive cutaneous capillary endothelial proliferation induced by camrelizumab: a case report. Translational Cancer Research 11 : 2940-2945, No. 8, Aug 2022. Available from: URL: http://​doi.​org/​10.​21037/​tcr-22-426
Metadaten
Titel
Camrelizumab
Reactive cutaneous capillary endothelial proliferation: case report
Publikationsdatum
01.07.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-42199-5

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drug

Case report

Antituberculars